Matches in SemOpenAlex for { <https://semopenalex.org/work/W2319312370> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2319312370 endingPage "P37" @default.
- W2319312370 startingPage "P37" @default.
- W2319312370 abstract "BACKGROUND Rapamycin (RAPA) is a new makrolide type immunosuppressive drug that has been controversial discussed to induce platelet hyperreagibility. In contrast to mycofenolate mofetil (MMF) platelet activation has been confirmed under azathioprin (AZA) therapy. METHODS In a substudy of a clinical trial platelet function of renal transplant patients treated with AZA (n=6) or MMF (n=6) was investigated before and 3 months after conversion to rapamycin. CD 62P, PAC1, platelet-monocyte interaction[CD41, CD11b (all as mean fluorescence intensity, MFI)] and CD40L (%+ platelets) was assessed by flow cytometry. RESULTS In AZA treated patients CD 62P decreases significantly (p<0,05) from 193±56 to 139±81 and CD41 (MFI) from 1530±260 to 576±218. CD11b (505±128 to 327±78) and CD40L (34±4 to 28±11) were also reduced but did not reach statistical significance. In an additional vitro investigation incubation of whole blood with increasing doses of rapamycin (from 50 to 1000ng/ml) did not result in any significant changes of platelet activation parameters. Platelet function in former MMF treated patients was unchanged after conversion to RAPA. CONCLUSION The conversion of immunosuppression from AZA to RAPA leads to a slight decrease of previous platelet activation. We found no evidence for increased platelet activation in RAPA patients. Clinical Pharmacology & Therapeutics (2005) 79, P37–P37; doi: 10.1016/j.clpt.2005.12.134" @default.
- W2319312370 created "2016-06-24" @default.
- W2319312370 creator A5036813228 @default.
- W2319312370 creator A5054581797 @default.
- W2319312370 creator A5067758966 @default.
- W2319312370 date "2006-02-01" @default.
- W2319312370 modified "2023-09-27" @default.
- W2319312370 title "PII-9Improved platelet function in renal transplant patients after conversion from azathioprin to rapamycin" @default.
- W2319312370 doi "https://doi.org/10.1016/j.clpt.2005.12.134" @default.
- W2319312370 hasPublicationYear "2006" @default.
- W2319312370 type Work @default.
- W2319312370 sameAs 2319312370 @default.
- W2319312370 citedByCount "0" @default.
- W2319312370 crossrefType "journal-article" @default.
- W2319312370 hasAuthorship W2319312370A5036813228 @default.
- W2319312370 hasAuthorship W2319312370A5054581797 @default.
- W2319312370 hasAuthorship W2319312370A5067758966 @default.
- W2319312370 hasConcept C126322002 @default.
- W2319312370 hasConcept C134018914 @default.
- W2319312370 hasConcept C159641895 @default.
- W2319312370 hasConcept C171779818 @default.
- W2319312370 hasConcept C185592680 @default.
- W2319312370 hasConcept C203014093 @default.
- W2319312370 hasConcept C2777921159 @default.
- W2319312370 hasConcept C2780252810 @default.
- W2319312370 hasConcept C2781184567 @default.
- W2319312370 hasConcept C2909935303 @default.
- W2319312370 hasConcept C2911091166 @default.
- W2319312370 hasConcept C3018697912 @default.
- W2319312370 hasConcept C553184892 @default.
- W2319312370 hasConcept C71924100 @default.
- W2319312370 hasConcept C89560881 @default.
- W2319312370 hasConcept C98274493 @default.
- W2319312370 hasConceptScore W2319312370C126322002 @default.
- W2319312370 hasConceptScore W2319312370C134018914 @default.
- W2319312370 hasConceptScore W2319312370C159641895 @default.
- W2319312370 hasConceptScore W2319312370C171779818 @default.
- W2319312370 hasConceptScore W2319312370C185592680 @default.
- W2319312370 hasConceptScore W2319312370C203014093 @default.
- W2319312370 hasConceptScore W2319312370C2777921159 @default.
- W2319312370 hasConceptScore W2319312370C2780252810 @default.
- W2319312370 hasConceptScore W2319312370C2781184567 @default.
- W2319312370 hasConceptScore W2319312370C2909935303 @default.
- W2319312370 hasConceptScore W2319312370C2911091166 @default.
- W2319312370 hasConceptScore W2319312370C3018697912 @default.
- W2319312370 hasConceptScore W2319312370C553184892 @default.
- W2319312370 hasConceptScore W2319312370C71924100 @default.
- W2319312370 hasConceptScore W2319312370C89560881 @default.
- W2319312370 hasConceptScore W2319312370C98274493 @default.
- W2319312370 hasIssue "2" @default.
- W2319312370 hasLocation W23193123701 @default.
- W2319312370 hasOpenAccess W2319312370 @default.
- W2319312370 hasPrimaryLocation W23193123701 @default.
- W2319312370 hasRelatedWork W2034453920 @default.
- W2319312370 hasRelatedWork W2058193075 @default.
- W2319312370 hasRelatedWork W2086046353 @default.
- W2319312370 hasRelatedWork W2088204908 @default.
- W2319312370 hasRelatedWork W2089152939 @default.
- W2319312370 hasRelatedWork W2131567659 @default.
- W2319312370 hasRelatedWork W2139505057 @default.
- W2319312370 hasRelatedWork W229396605 @default.
- W2319312370 hasRelatedWork W4210415050 @default.
- W2319312370 hasRelatedWork W4233287756 @default.
- W2319312370 hasVolume "79" @default.
- W2319312370 isParatext "false" @default.
- W2319312370 isRetracted "false" @default.
- W2319312370 magId "2319312370" @default.
- W2319312370 workType "article" @default.